UBS Group AG: Basel III Pillar 3 Disclosure Summary (Q2 2019)
Business Context and Reporting Period
This Form 6-K filing contains the Basel III Pillar 3 disclosure report for UBS Group AG and its significant regulated subsidiaries as of June 30, 2019. The report details regulatory capital, risk-weighted assets (RWA), leverage, liquidity, and total loss-absorbing capacity (TLAC) in accordance with FINMA and BCBS requirements. UBS is classified as a Systemically Relevant Bank (SRB) in Switzerland and a Global Systemically Important Bank (G-SIB).
Key Financial Metrics (Consolidated)
| Metric | Value (USD) | Ratio / % |
|---|---|---|
| Common Equity Tier 1 (CET1) Capital | $34.9 billion | 13.33% of RWA |
| Total Risk-Weighted Assets (RWA) | $262.1 billion | - |
| Basel III Leverage Ratio | $49.9 billion (Tier 1 Capital) | 5.49% |
| Liquidity Coverage Ratio (LCR) | $176.2 billion (HQLA) | 145% |
| Total Loss-Absorbing Capacity (TLAC) | $87.4 billion | 33.34% of RWA / 9.59% of LRD |
Material Changes vs. Prior Period (Q1 2019)
- Capital: CET1 capital increased by $0.3 billion to $34.9 billion, driven by operating profit and foreign currency translation, partially offset by shareholder returns and share repurchases.
- Risk-Weighted Assets: RWA decreased by $5.4 billion to $262.1 billion. The decline was primarily due to reductions in credit risk RWA ($3.4 billion) and market risk RWA ($2.0 billion).
- Liquidity: High-quality liquid assets (HQLA) decreased by $9.9 billion to $176.2 billion, reflecting lower average cash balances due to increased funding consumption by business divisions. Consequently, the LCR decreased by 8 percentage points to 145%.
- Market Risk: Market risk RWA decreased by $1.8 billion, largely driven by a reduction in regulatory add-ons following monthly risk assessments.
Outlook, Risks, and Management Commentary
- Regulatory Compliance: UBS remains well above minimum regulatory requirements for capital, leverage, and liquidity. The CET1 ratio available after meeting minimum requirements is 8.83%.
- Interest Rate Risk (IRRBB): Under the most adverse "Parallel up" scenario (+200 bps USD), the Economic Value of Equity (EVE) would decrease by $4.5 billion (9.0% of Tier 1 capital), which is below the 15% regulatory outlier threshold.
- TLAC Structure: The filing introduces new TLAC disclosures for the first time. UBS Group AG is the resolution entity; new loss-absorbing instruments are issued directly by UBS Group AG, while existing instruments issued by UBS Group Funding (Switzerland) AG are expected to be assumed by the parent in Q4 2019.
- Future Regulatory Changes: The BCBS agreed to align leverage ratio measurement for client-cleared derivatives with SA-CCR, effective January 1, 2022, which is expected to mitigate potential leverage ratio impacts.
Key Facts for Investor Verification
- Capital Adequacy: Verify that the CET1 ratio of 13.33% and Total Capital ratio of 21.49% comfortably exceed the Swiss SRB requirements (13.89% and 21.22% respectively as of June 30, 2019).
- Liquidity Buffer: Confirm the LCR of 145% remains above the FINMA minimum of 110% despite the decline in HQLA.
- TLAC Sufficiency: Note that TLAC available ($87.4 billion) significantly exceeds the required TLAC ($61.9 billion), providing a robust buffer for resolution.
- RWA Drivers: Monitor the continued reduction in RWA, specifically the impact of excluding non-credit bearing collar financing transactions from credit risk RWA.
- Subsidiary Metrics: Review standalone metrics for UBS AG (CET1 17.41%, LCR 145%) and UBS Switzerland AG (CET1 11.02%, LCR 138%) to ensure local regulatory compliance.